Considering its importance in cholinergic system modulation, acetylcholinesterase (AchE) has become a prime therapeutic target in the treatment of Alzheimer’s disease (AD) [7,8,9]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.